September 19 Product: Johnson & Johnsons Rybrevant Indication: Non-small cell lung cancer Johnson & Johnson racked up its third non-small cell lung cancer (NSCLC) approval for Rybrevant this year as the FDA greenlit the bispecific antibody plus chemotherapy for the second-line treatment of locally advanced or metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 19 deletions or L858R substitution mutations
Feist Cardiovascular Research Fellowship to RP and the Endowed Chair in Diabetes to SKJ from the Center for Cardiovascular Diseases and Sciences (CCDS), LSUHSC, Shreveport, as well as grants to SKJ from the National Institutes of Health/National Center for Complementary and Integrative Health (RO1 AT007442, 2013-16)
Diabetes 74 (Suppl.1), 882-P (2025)
Because of its abundance, GSH plays a key role in maintaining cellular redox homeostasis and in cellular mechanisms that protect against oxidative stress
Immune system boost Glutathione can strengthen your immune system by supporting T cells, which help manage immune responses, and natural killer (NK) cells, which get rid of infected or abnormal cells
L.MuydermanH.KwekP